What Did Not Change on July 23 No approved indication or dosing label exists The committee did not create an approved indication for ulcerative colitis, tendon injury, ligament injury, muscle recovery, joint pain, gut symptoms, or general wellness
Some -- like insulin and GLP-1s -- are FDA-approved medicines that have been rigorously tested
When evaluating providers, look for: Peptide-specific experience: Many physicians lack training in this area
Published mechanistic work points to BPC-157 enhancing VEGFR2 expression and downstream signalling activity in endothelial cells, rather than acting as a direct VEGFR2 ligand
They may act through different pathways
Heres your science-backed, no-hype guidein plain English